期刊
ACS INFECTIOUS DISEASES
卷 7, 期 6, 页码 1369-1388出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsinfecdis.0c00646
关键词
SARS-CoV-2; COVID-19; pathogenesis; diagnosis; therapy; antibody; vaccine; inhibitor; transmission; pandemic
资金
- National Key R&D Program of China [2018YFC1105402]
- National Natural Science Foundation of China [21875189, 61935017]
- National Science Basic Research Plan in Shaanxi Province of China [2020JQ-148, 2020GXLH-Z-013, 2019KJXX-064]
- Fundamental Research Funds for the Central Universities
The SARS-CoV-2 outbreak that started at the end of 2019 has impacted over 58 million people globally, resulting in more than 1.38 million deaths and profound effects on the world. Current understanding of the source, transmission characteristics, and pathogenic mechanism of SARS-CoV-2 has been summarized, along with ongoing efforts in diagnostic methods and potential treatment strategies, including clinical trials for antibodies, vaccines, and inhibitors.
The SARS-CoV-2 outbreak that emerged at the end of 2019 has affected more than 58 million people with more than 1.38 million deaths and has had an incalculable impact on the world. Extensive prevention and treatment measures have been implemented since the pandemic. In this Review, we summarize current understanding on the source, transmission characteristics, and pathogenic mechanism of SARS-CoV-2. We also detail the recent development of diagnostic methods and potential treatment strategies of COVID-19 with focus on the ongoing clinical trials of antibodies, vaccines, and inhibitors for combating the emerging coronavirus.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据